1967MO Preliminary Efficacy and Safety of Disitamab Vedotin (DV) with Pembrolizumab (P) in Treatment (Tx)-Naive HER2-expressing, Locally Advanced or Metastatic Urothelial Carcinoma (la/muc): RC48G001 Cohort C
Annals of Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要